外体在癌症中的瘤原生和瘤杀伤性质;展望未来
Zahra Abbasi-Malati1, Seyed Ghader Azizi2, Soheil Zamen Milani3
1Department of Applied Cell Sciences, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.
Cell communication and signaling : CCS
|February 15, 2024
概括
细胞外囊泡 (EVs),特别是外体 (Exos),通过转移信号分子,对癌症的进展至关重要. 这篇评论仔细研究了Exos如何驱动致癌行为,并探讨了干细胞衍生的Exos.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 纳米医学是一种纳米医学.
背景情况:
- 新出现的数据突出显示了细胞外囊泡 (EVs),特别是外体 (Exos) 在癌症进展中的关键作用.
- 外体是癌细胞释放的纳米尺寸囊泡,促进细胞间通信和传输信号分子.
- 外会影响瘤微环境,免疫细胞活动,促进瘤细胞扩张和转移.
研究的目的:
- 仔细检查各种瘤细胞系衍生的外体的致癌行为背后的分子机制.
- 讨论来自不同类型干细胞 (SC) 的外体的杀瘤性质.
主要方法:
- 文献综述和对癌症中外体细胞功能现有研究的分析.
- 对参与外体介导瘤发生的分子机制的审查.
- 详细讨论干细胞衍生的外体细胞特性.
主要成果:
- 外体细胞通过转移瘤原因子,改变瘤微环境和免疫反应来促进细胞间交叉通讯.
- 通过外体细胞调节瘤和非癌细胞行为的特定分子机制正在研究中.
- 来自干细胞的外体显示出潜在的瘤杀伤性质.
结论:
- 外基因组通过复杂的分子机制在癌症的发展和进展中发挥着多方面的作用.
- 了解外体介导的瘤发生对于开发新型癌症疗法至关重要.
- 来自干细胞的外体细胞代表了癌症治疗的有前途的治疗途径.
相关概念视频
Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Mesenchymal Stem Cells
4.7K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.7K


